You are viewing: Canada Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Canada Latent TB Testing Market was valued at $22.57 Million in 2024 and projected to reach to $24.85 Million by 2029, representing a compound annual growth rate of 1.9%. Canada's latent TB testing market demonstrates stable, predictable growth driven by established public health policies and mandatory screening requirements for immigrants and healthcare workers.

Canada Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Latent TB Testing Market Trends and Insights

  • This modest growth reflects Canada's established healthcare infrastructure and existing TB screening programs, which have already achieved significant population coverage.
  • In Canada, latent TB testing remains a critical component of public health strategy, particularly among high-risk populations including recent immigrants, healthcare workers, and Indigenous communities. The Canadian market is characterized by steady demand driven by ongoing immigration screening requirements and occupational health protocols.
  • Canada's universal healthcare system supports consistent testing access, though growth is tempered by market maturity and the relatively low incidence of active TB disease.
  • Between 2024 and 2029, Canada will continue to refine its latent TB diagnostic approaches, with incremental adoption of newer testing methodologies and integration into existing provincial health programs..

Key Market Statistics

  • CAGR (2024-2029) 1.9% CAGR
  • Market Size, 2024 ~USD 22.57 Million
  • Forecast, 2029 ~USD 24.85 Million
  • Country Canada

Canada Latent TB Testing Market Overview

Market Size & Growth :

Canada's latent TB testing market valued at $22.57 million in 2024, projected to reach $24.85 million by 2029 with a CAGR of 1.9%, reflecting steady but modest expansion in an established healthcare system.

Healthcare Infrastructure Maturity :

Canada's advanced healthcare infrastructure and comprehensive TB screening programs have achieved significant population coverage, resulting in lower growth rates compared to emerging markets with untapped testing potential.

Public Health Integration :

Latent TB testing is deeply integrated into Canada's public health framework, with provincial health authorities and federal programs driving standardized screening protocols across diverse populations and high-risk groups.

Immigration & Border Health :

Canada's immigration screening requirements and border health protocols create consistent demand for latent TB testing, particularly among newcomers and international travelers entering the country.

Canada Latent TB Testing Market Dynamics

  • The market benefits from strong regulatory frameworks and integration with provincial health systems, though growth is constrained by already-high population screening coverage and mature diagnostic adoption.
  • Future expansion will likely stem from enhanced surveillance programs, updated clinical guidelines, and increased testing among vulnerable populations rather than market penetration gains.
  • The modest 1.9% CAGR reflects market saturation in developed regions, with opportunities emerging from improved accessibility in remote areas and integration of newer diagnostic technologies into existing screening infrastructure..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Canada's latent TB testing market is valued at $22.57 million in 2024 with projected growth to $24.85 million by 2029.
    • Canada experiences modest 1.9% CAGR growth, reflecting market maturity and established screening infrastructure.
    • In Canada, immigration screening and occupational health requirements drive consistent testing demand.
    • Canada's universal healthcare system ensures stable market access, though growth is constrained by low active TB incidence.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Canada Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    CANADA: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES1.071.21.191.191.21.221.241.271.3
    DIAGNOSTIC LABORATORIES13.8315.6115.6115.7215.9716.3116.7617.282.1
    HOSPITALS & CLINICS4.525.095.075.15.175.275.45.561.8
    OTHER END USERS0.630.710.70.70.710.710.730.741.1
    TOTAL20.0522.622.5722.7123.0423.5124.1324.851.9

    Target Audience

    • Diagnostic Device Manufacturers : Need Canada-specific market data to assess market size, growth potential, regulatory pathways, and competitive positioning for latent TB testing products in a mature healthcare system.
    • Healthcare System Administrators : Require insights into testing demand forecasts, provincial variations, and screening program trends to optimize resource allocation and procurement strategies across Canadian health authorities.
    • Public Health Officials : Seek market intelligence on testing coverage gaps, emerging diagnostic technologies, and population-specific screening needs to inform TB elimination strategies and public health policy development.
    • Investment & Consulting Firms : Need comprehensive Canada market analysis including growth drivers, competitive dynamics, and forecast data to support due diligence, strategic planning, and investment decisions in healthcare diagnostics.
    • Laboratory & Testing Service Providers : Require market sizing and growth projections specific to Canada to evaluate expansion opportunities, service demand trends, and competitive positioning within provincial healthcare networks.

    Reasons to Buy this Report

    • Regulatory & Policy Insights : Understand Canada's provincial and federal TB screening mandates, immigration health requirements, and public health policies that drive consistent testing demand across healthcare systems.
    • Market Segmentation Data : Access detailed breakdown of Canada's latent TB testing market by diagnostic method, end-user type, and geographic region to identify high-opportunity segments and provincial variations.
    • Competitive Landscape Analysis : Evaluate key players, diagnostic technology adoption rates, and market positioning specific to Canada's healthcare environment to inform strategic partnerships and market entry strategies.
    • Growth Driver Identification : Identify specific factors fueling Canada's 1.9% CAGR including immigration trends, healthcare worker screening, and emerging testing technologies to capitalize on market expansion opportunities.
    • Forecast Accuracy & Planning : Leverage Canada-specific projections through 2029 with validated methodologies to support business planning, investment decisions, and resource allocation in the Canadian healthcare market.

    Frequently asked questions

    What is the current size of Canada's latent TB testing market?

    Canada's latent TB testing market was valued at $22.57 million in 2024 and is expected to reach $24.85 million by 2029.

    What is the growth rate of latent TB testing in Canada?

    Canada's latent TB testing market is growing at a compound annual growth rate of 1.9% from 2024 to 2029.

    Which populations drive latent TB testing demand in Canada?

    In Canada, latent TB testing is primarily driven by immigration screening requirements, healthcare worker occupational health protocols, and testing among Indigenous communities.

    How does Canada's healthcare system support latent TB testing?

    Canada's universal healthcare system ensures consistent access to latent TB testing across provinces, supporting steady demand through public health programs and occupational health initiatives.

    Why is Canada's latent TB testing market growth relatively modest?

    Canada's 1.9% CAGR reflects market maturity, established screening infrastructure, and the country's relatively low incidence of active tuberculosis disease.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status